Associated Papers
CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy.
Ma J et al.
Journal of Digestive Diseases, 2008
Factors affecting the maintenance stable warfarin dosage in Hong Kong Chinese patients.
Lee VW et al.
Journal of Thrombosis and Thrombolysis, 2005
Polymorphism induced sensitivity to warfarin: a review of the literature.
Palkimas MP et al.
Journal of Thrombosis and Thrombolysis, 2003
CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians.
Rettie AE et al.
Blood, 2003
Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.
Takahashi H et al.
The Pharmacogenomics Journal, 2003
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4.
Roetto A et al.
Blood, 2002
Leu208Val and Ile181Leu variants of cytochrome P450 CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population.
Zarza J et al.
Blood, 2002
Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients.
Leung AY et al.
Blood, 2001
Select a paper to view details